CEO Michael Pearson

Valeant Pharmaceuticals (VRX) to Name New CEO as Pearson Still in Hospital

Valeant Pharmaceuticals International Inc (NYSE:VRX) is considering to name a new chief executive to lead the company while Michael Pearson is still in the hospital due to severe pneumonia, according to the Wall Street...

Bill Ackman Still Confident with Valeant Pharmaceuticals (VRX) CEO

Bill Ackman, the head of Pershing Square Capital Management, is still confident with the leadership of Michael Pearson, the CEO of Valeant Pharmaceuticals (NYSE:VRX) although the company’s stock price continues to slide amid allegations...

Recent posts

Popular categories